Company overview
While on May 7th, 2025, the Company announced entering into an agreement with Shionogi & Co., Ltd. to transfer the pharmaceutical business and our stake in TORII PHARMACEUTICAL CO., LTD.(''Torii''), a consolidated subsidiary of JT, the JT Group's performance and initiatives described on this page include those associated with the pharmaceutical business and Torii.
Please see the press releases on our website for the details.
As announced on September 1, 2025, the transfer of Torii shares has been completed. Please see the press release on our website for the details.
Corporate profile
-
Name
Japan Tobacco Inc.
-
Head office
1-1, Toranomon 4-chome, Minato-ku
Tokyo 105-6927 JAPAN -
Date of establishment
April 1, 1985
-
Paid-in capital
¥100 billion
-
President & CEO
Masamichi Terabatake
-
Number of employees (As of December 31, 2024)
53,593 (Consolidated) / 5,994 (Non-Consolidated)
Revenue (Results in FY 2024)
The JT Group is a leading global tobacco company and our products are sold in over 130 markets. In addition to the tobacco business, we operate pharmaceutical and processed food businesses.
Revenue breakdown by business segment
